Search

Y Wang

Well-Differentiated Papillary Mesothelioma of the Peritoneum is Genetically Distinct from Malignant Mesothelioma
BAP1 Haploinsufficiency Predicts a Distinct Immunogenic Class of Malignant Peritoneal Mesothelioma
BIRC6-targeting as potential therapy for advanced, enzalutamide-resistant prostate cancer
Heterogeneity in the inter-tumor transcriptome of high risk prostate cancer
A Meta-Analysis Approach for Characterizing Pan-Cancer Mechanisms of Drug Sensitivity in Cell Lines

Published with Hugo Blox Builder — the free, open source website builder that empowers creators.